Skip to main content

Too Expensive

Premium

Cancer care is expensive — that's certainly not a new concept. But a new report commissioned by Lancet Oncology shows just how expensive and unaffordable care is becoming, reports Reuters' Kate Kelland. An "explosion" of new technology and drugs, combined with rising rates of the disease, mean that patients are becoming less and less able to pay for the latest life-saving advances, she adds. The report says there should be a shift in thinking to ensure treatments are priced fairly, and that new technologies add tangible value to the cancer research field. "The cost of new cancer cases is already estimated to be about $286 billion a year, with medical costs making up more than half the economic burden and productivity losses account for nearly a quarter, according to Economist Intelligence United data cited in the report," Kelland says. "The report, led by Richard Sullivan of Britain's King's Health Partners Integrated Cancer Centre in London, said policy-makers, doctors, patients groups and the health industry should work together to find ways to stem future cost rises."

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.